🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bioneer Corporation (KOSDAQ:064550)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,770.00
+1,300.00 (20.09%)
Nov 20, 2026, 3:30 PM KST

Bioneer Revenue

Bioneer had revenue of 96.15B KRW in the quarter ending June 30, 2026, with 8.91% growth. This brings the company's total for the last twelve months to 345.88B, up 15.87% year-over-year. In the year 2025, Bioneer had annual revenue of 330.11B with 12.29% growth. That makes Bioneer the 15,669th largest company in the world by revenue and 778th in South Korea.

Revenue (ttm)
345.88B
Revenue Growth
+15.87%
P/S Ratio
0.58
Revenue / Employee
903.09M
Employees
383
Market Cap
200.55B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Probiotics 307.14B 88.2%
  • Research and Molecular Diagnostics 38.78B 11.1%
  • RNAi new Drug Development 2.40B 0.7%

By Geography

Chart
  • South Korea 313.82B 95.1%
  • Asia 11.37B 3.4%
  • America 3.71B 1.1%
  • Europe 590.95M 0.2%
  • Africa 358.19M 0.1%
  • Other 252.79M 0.1%
Fiscal year ended Dec 31, 2025 See the full Bioneer breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025330.11B36.14B12.29%
Dec 31, 2024293.98B30.74B11.68%
Dec 31, 2023263.24B44.84B20.53%
Dec 31, 2022218.39B-5.35B-2.39%
Dec 31, 2021223.74B16.76B8.10%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GC Cell162.00B
MEDIPOST74.84B
HLB Therapeutics64.45B
GC Genome32.64B
SillaJen10.77B
Anterogen.Co.,Ltd.9.29B
NeoImmuneTech6.60B
MedPacto4.80B
Revenue Rankings